Simon Plyte | CSO
Biomunex Pharmaceuticals

Dr Plyte has over 25 years of experience in drug development both in Big Pharma and Small Biotech predominantly applied to Oncology and immuno-Oncology. Over the last 15 years he has focussed on the development of biologics with an emphasis of multi-specific antibody formats having differing drug modalities. As CSO of Biomunex, he is leading the development of innovative approaches for the treatment of cancer and is advancing the first-in-class MAIT engagers towards clinical development